Home › Brain Diseases › Georgia › Atlanta
Brain Diseases clinical trials in Atlanta, GA
4 studies for Brain Diseases are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #047, Atlanta
- Vima Site #045, Decatur · 6 mi away
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Atlanta
- Clinical Site, Decatur · 6 mi away
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
- CenExel iResearch, LLC (CenExel iRA), Decatur · 6 mi away
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
RecruitingPhase 3
- Emory University School of Medicine, Atlanta
About Brain Diseases
Brain diseases affect different functions of the body from memory, speech, thinking clearly, how well the different organs work, or even movement.
More about Brain Diseases on MedlinePlus
Brain Diseases trials in other cities
- New York City, NY7 studies
- Orlando, FL7 studies
- Boston, MA7 studies
- St. Louis, MO7 studies
- Miami, FL6 studies
- Houston, TX6 studies
- Pittsburgh, PA6 studies
- Washington, DC6 studies
- Philadelphia, PA5 studies
- San Diego, CA5 studies
- West Palm Beach, FL4 studies
- Akron, OH4 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.